SCHEMBL6879512

SCHEMBL6879512

C[C@H](CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CCC4CC(O)(O)C(O)C[C@]4(C)[C@H]3CC[C@]12C)C(=O)O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPBAR1 Q8TDU6 6/20 0.55
EPHA2 P29317 4/20 0.52
CASP7 P55210 3/20 0.52
HSD17B10 Q99714 3/20 0.52
TDP1 Q9NUW8 3/20 0.52
TP53 P04637 2/20 0.52
MAPK1 P28482 2/20 0.52
BLM P54132 2/20 0.52
AKR1B10 O60218 2/20 0.52
AKR1B1 P15121 2/20 0.52
LMNA P02545 2/20 0.52
MDM4 O15151 1/20 0.52
CYP3A4 P08684 1/20 0.52
MAPT P10636 1/20 0.52
HSPD1 P10809 1/20 0.52
VDR P11473 1/20 0.52
TSHR P16473 1/20 0.52
PTPN2 P17706 1/20 0.52
PTPN1 P18031 1/20 0.52
BRCA1 P38398 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1490581 1.00 GPBAR1 (0.55) GPBAR1EPHA2CASP7HSD17B10TDP1
SCHEMBL2155401 0.89 CYP2D6 (0.62) TP53LMNAUSP2POLA1CDC25A
SCHEMBL29689457 0.89 CYP2D6 (0.62) TP53LMNAUSP2POLA1CDC25A
SCHEMBL5154450 0.87 VDR (0.69) GPBAR1EPHA2CASP7HSD17B10TDP1
SCHEMBL5667888 0.87 VDR (0.69) GPBAR1EPHA2CASP7HSD17B10TDP1
SCHEMBL5790619 0.86 ST6GAL1 (0.50) GPBAR1EPHA2CASP7HSD17B10TDP1
SCHEMBL232939 0.86 GPBAR1 (0.57) GPBAR1EPHA2CASP7HSD17B10TDP1
SCHEMBL22495528 0.85 GPBAR1 (0.56) GPBAR1EPHA2CASP7HSD17B10TDP1
SCHEMBL9580266 0.85 OSBP (0.52) GPBAR1EPHA2CASP7HSD17B10TDP1
SCHEMBL7528741 0.84 GRIN2A (0.52) GPBAR1EPHA2CASP7HSD17B10TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040152146-A1 Methods for screening compounds for use in the treatment of disease ENCORE PHARMACEUTICALS, INC. 2004-08-05 US disclosed
WO-2004055200-A2 METHODS FOR SCREENING COMPOUNDS FOR USE IN THE TREATMENT OF DISEASE ENCORE PHARMACEUTICALS, INC. (US) 2004-07-01 WO disclosed